Suppr超能文献

五种肺表面活性物质因子(LSF)制剂在成人呼吸窘迫综合征(ARDS)动物模型中的剂量反应比较。

Dose-response comparisons of five lung surfactant factor (LSF) preparations in an animal model of adult respiratory distress syndrome (ARDS).

作者信息

Häfner D, Beume R, Kilian U, Krasznai G, Lachmann B

机构信息

Byk Gulden, Department of Respiratory Pharmacology, Konstanz, Germany.

出版信息

Br J Pharmacol. 1995 Jun;115(3):451-8. doi: 10.1111/j.1476-5381.1995.tb16354.x.

Abstract
  1. We have examined the effects of five different lung surfactant factor (LSF) preparations in the rat lung lavage model. In this model repetitive lung lavage leads to lung injury with some similarities to adult respiratory distress syndrome with poor gas exchange and protein leakage into the alveolar spaces. These pathological sequelae can be reversed by LSF instillation soon after lavage. 2. The tested LSF preparations were: two bovine: Survanta and Alveofact: two synthetic: Exosurf and a protein-free phospholipid based LSF (PL-LSF) and one Recombinant LSF at doses of 25, 50 and 100 mg kg-1 body weight and an untreated control group. 3. Tracheotomized rats (10-12 per dose) were pressure-controlled ventilated (Siemens Servo Ventilator 900C) with 100% oxygen at a respiratory rate of 30 breaths min-1, inspiration expiration ratio of 1:2, peak inspiratory pressure (PIP) of 28 cmH2O at positive end-expiratory pressure (PEEP) of 8 cmH2O. Two hours after LSF administration, PEEP and in parallel PIP was reduced from 8 to 6 (1st reduction), from 6 to 3 (2nd reduction) and from 3 to 0 cmH2O (3rd reduction). 4. Partial arterial oxygen pressure (PaO2, mmHg) at 5 min and 120 min after LSF administration and during the 2nd PEEP reduction (PaO2(PEEP23/3)) were used for statistical comparison. All LSF preparations caused a dose-dependent increase for the PaO2(120'), whereas during the 2nd PEEP reduction only bovine and recombinant LSF exhibited dose-dependency. Exosurf did not increase PaO2 after administration of the highest dose. At the highest dose Exosurf exerted no further improvement but rather a tendency to relapse. The bovine and the Recombinant LSF are superior to both synthetic LSFpreparations.5. In this animal model and under the described specific ventilatory settings, even between bovine LSFpreparations there are detectable differences that are pronounced when compared to synthetic LSFwithout any surfactant proteins. We conclude that the difference between bovine and synthetic LSFpreparations can be overcome by addition of the surfactant protein C.
摘要
  1. 我们在大鼠肺灌洗模型中研究了五种不同肺表面活性物质因子(LSF)制剂的作用。在该模型中,重复肺灌洗会导致肺损伤,与成人呼吸窘迫综合征有一些相似之处,表现为气体交换不良和蛋白质渗漏到肺泡腔中。灌洗后不久通过滴注LSF可逆转这些病理后遗症。2. 所测试的LSF制剂有:两种牛源性的:固尔苏和珂立苏;两种合成的:爱全乐和一种无蛋白磷脂基LSF(PL-LSF)以及一种重组LSF,剂量分别为25、50和100mg/kg体重,还有一个未治疗的对照组。3. 对气管切开的大鼠(每个剂量10 - 12只)使用西门子Servo Ventilator 900C进行压力控制通气,吸入100%氧气,呼吸频率为每分钟30次,吸呼比为1:2,呼气末正压(PEEP)为8cmH₂O时的吸气峰压(PIP)为28cmH₂O。给予LSF两小时后,PEEP以及与之平行的PIP从8cmH₂O降至6cmH₂O(第一次降低),从6cmH₂O降至3cmH₂O(第二次降低),从3cmH₂O降至0cmH₂O(第三次降低)。4. 在给予LSF后5分钟和120分钟以及第二次降低PEEP期间(PaO₂(PEEP23/3))的动脉血氧分压(PaO₂,mmHg)用于统计比较。所有LSF制剂均使PaO₂(120')呈剂量依赖性增加,而在第二次降低PEEP期间,只有牛源性和重组LSF表现出剂量依赖性。给予最高剂量后,爱全乐并未增加PaO₂。在最高剂量时,爱全乐没有进一步改善,反而有复发趋势。牛源性和重组LSF优于两种合成LSF制剂。5. 在该动物模型以及所描述的特定通气设置下,即使在牛源性LSF制剂之间也存在可检测到的差异,与不含任何表面活性蛋白的合成LSF相比,这种差异更为明显。我们得出结论,通过添加表面活性蛋白C可以克服牛源性和合成LSF制剂之间的差异。
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac43/1908419/0ee42fbac8b4/brjpharm00186-0079-a.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验